InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
3
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the full record of transactions filed by Santos David A, Director. Insider active across 1 company, notably RIGEL PHARMACEUTICALS INC. Cumulatively, 10 reports have been published. Breakdown: 0 buy · 3 sells. Total volume traded: €57k. Activity tracked since 24 January 2022. The latest transaction was disclosed on 17 February 2026 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Santos David A
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations10 total
19,430 shares0Common StockSEC:0000905148-26-000954:0
3,546 shares@ US$34.6230.9% of flowCommon StockSEC:0000905148-26-000679:0
5,718 shares@ US$36.0152.0% of flowCommon StockSEC:0000905148-26-000498:0
2,125 shares@ US$20.92175.5% of flowCommon StockSEC:0000905148-25-000412:0
19,717 shares0Common StockSEC:0000905148-25-000299:0
5,601 shares@ US$1.1310.2% of flowCommon StockSEC:0000905148-24-000447:0
209,000 shares0Common StockSEC:0000905148-24-000307:0
5,388 shares@ US$1.660214.3% of flowCommon StockSEC:0001140361-23-004733:0
80,000 shares0Common StockSEC:0001140361-23-003439:0
50,000 shares0Common StockSEC:0001567619-22-001780:0
10 of 10 declarations
About Santos David A
David A. Santos is the Executive Vice President and Chief Commercial Officer at Rigel Pharmaceuticals Inc. In this role, he oversees the company's commercial operations, contributing to the growth strategy. With experience in the pharmaceutical sector, he plays a key role in the leadership of Rigel Pharmaceuticals Inc.
